$ALT news: pivotal AUD trial kickoff — historically a 4.2% median next-day move (3/5 higher)
How ALT has reacted before
| Report | Next-day move |
|---|---|
| Aug 2026 | -2.2% |
| Aug 2025 | +7.1% |
| May 2025 | -4.2% |
| Feb 2025 | +8.1% |
| Sep 2024 | +1.4% |
Median absolute move 4.2% · higher 3 of 5 · n=5
Altimmune, Inc. ($ALT) says it’s initiating a pivotal trial for AUD, citing promising Phase 2 results and strategic financial plans to support growth.
How $ALT has reacted to earnings
| Report | Next-day |
|---|---|
| Aug 2026 | -2.2% |
| Aug 2025 | +7.1% |
| May 2025 | -4.2% |
| Feb 2025 | +8.1% |
| Sep 2024 | +1.4% |
Base rate (n=5):
- Median absolute next-day move: 4.2%
- Higher: 3 of 5
- Biggest up day: +8.1%
- Biggest down day: -4.2%